EXACT Sciences Corporation Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 24 Posts
1 2
Stocks For You To Swing-Trade: EXAS, UNM, ROKU
Article By: Ryan Mallory Wednesday, April 17, 2019 7:35 AM EDT
Take a look at three trading ideas to prep you for the next trading session.
In this article: UNM, EXAS, ROKU
5 Stocks That May Sink The Market, Do Bonds Have A Secret Message
Article By: Michael J. Kramer Tuesday, February 26, 2019 9:32 AM EDT
US bonds are still very attractive compared to global rates and the spreads for US bonds got too wide and are now reverting to the mean.
In this article: SPY, TNX, CAT, HD, EXAS, GS, FB
Exact Sciences: Poised For Further Growth
Article By: TipRanks Sunday, November 4, 2018 3:17 PM EDT
Exact Sciences is moving forward on a solid foundation: a proven product, a new marketing initiative to expand – or even double – its reach. It’s no surprise that every analyst who has reviewed EXAS recently has given it a ‘Buy’ rating
In this article: PFE, EXAS
Weighing The Week Ahead: Should Investors Worry About The Yield Curve?
Article By: Jeff Miller Sunday, August 26, 2018 11:27 AM EDT
Much of the punditry is focused on a death watch for the bull market, with daily discuss of the flattening yield curve and speculation about when it will “invert.” This is not the right question.
In this article: AXL, MO, AMZN, TSLA, SPX, OLLI, LOW, NVAX, EXAS
10 Stock Tips From The Street’s Best Analysts
Article By: TipRanks Sunday, July 29, 2018 4:39 PM EDT
Using the updated stock screener from the generated results, these 10 stocks stood out. Bear in mind the analyst consensus is based on ratings from the last three months.
In this article: EW, MA, MPC, MPWR, AMZN, MU, EXAS, GOOGL, WIX, RETA
E Large Cap Stocks: Gainers And Losers In 2017
Article By: Arie Goren Saturday, December 30, 2017 12:24 PM EDT
Here are the best and the worst performers among Russell 1000 stocks in 2017, and 20 stocks that have a chance to perform well in 2018, which should be another good year for investors in large cap stocks.
5 Top-Ranked Profitable Stocks To Boost Your Portfolio
Article By: Zacks Investment Research Tuesday, October 17, 2017 3:24 PM EDT
Profitability analysis is used to measure the company’s ability to manage its revenues effectively and provide stunning returns to its investors.
In this article: NTDOY, NVMI, EXAS, FB, TRHC
Analysts Bullish On Exact Sciences After Positive Coverage Decision
Article By: The Fly Wednesday, May 31, 2017 2:40 PM EDT
The shares of EXACT Science are climbing after health insurance giant UnitedHealth agreed to cover the company's Cologuard test, starting July 1.
In this article: EXAS Also: UNH
Exact Sciences - Chart Of The Day
Article By: Jim Van Meerten Monday, May 8, 2017 3:04 PM EDT
Revenue expected to grow 109.00% this year and another 49.80% next year.
In this article: EXAS
Exact Sciences (EXAS) "Cup 'N Handle" Chart Is Bullish
Article By: Adam Makowka Thursday, March 2, 2017 10:00 PM EDT
2-yr weekly illustrates a "Cup 'n Handle" an imminent breakout is expected.
In this article: EXAS
Exact Sciences Reports Positive Results From Lung Cancer Test Study
Article By: KKD Healthcare Analytics Thursday, March 2, 2017 2:24 PM EDT
Exact Sciences Corporation reported that its collaboration with Mayo Clinics for developing a blood-based lung cancer test shows promising prospects.
In this article: EXAS
Drug Stocks Q4 Earnings Lineup For Feb 21: IRWD, MNTA, EXAS
Article By: Zacks Investment Research Tuesday, February 21, 2017 4:30 AM EDT
Momenta’s bottom-line performance has been decent so far, with its earnings surpassing expectations in three of the last four quarters. However, over the trailing four quarters, the company has recorded an average negative surprise of 75.74%.
In this article: MNTA, EXAS, IRWD Also: ALXN, TEVA, ZTS
5 Great Biotech Stocks To Buy Now
Article By: Swarup Gupta Tuesday, February 7, 2017 5:45 PM EDT
Biotechs have recovered substantially from the losses they suffered up to early last year. Adding biotech stocks to your portfolio looks like a smart option at this point.
In this article: CELG, CLLS, EXEL, EXAS, SNSS Also: BMRN
Earnings ESP
Article By: Zacks Investment Research Saturday, October 8, 2016 6:11 PM EDT
A number of healthcare companies are recording improvements in financial numbers. A sneak peek for some outperformers that boast a solid Zacks Rank and a positive Earnings ESP, could be a great idea for investors during the upcoming earnings season
In this article: BIIB, EXAS, UTHR, JNJ, AMGN, BMY
Quick Win By The Algorithm: EXAS
Article By: I Know First Research Sunday, July 24, 2016 12:00 PM EDT
On July 24th, 2016, the I Know First algorithm gave a bullish signal of 31.7 for the ticker EXAS with a predictability indicator of .23. In accordance with the algorithm’s prediction, EXAS experienced a Quick Win of a 54.25% increase in only 14 days
In this article: EXAS
Analysts' Wrap Up Digestive Disease Week: Synergy Pharmaceuticals, EXACT Sciences Corporation And Celgene Corporation
Article By: TipRanks Sunday, May 29, 2016 4:48 PM EDT
Synergy Pharmaceuticals Inc, EXACT Sciences Corporation, and Celgene Corporation presented data from studies on pipeline and approved drugs related to digestive illnesses at Digestive Disease Week, an annual gathering of physicians and researchers.
In this article: SGYP, CELG, EXAS
1 to 16 of 24 Posts
1 2